<b>Genetic polymorphisms in </b><b><i>NOS1AP</i></b><b> </b><b>affects insulin secretion in response to exenatide via nNOS/p38 MAPK/CREB signaling pathway in Chinese patients with type 2 diabetes mellitus</b>

Supplementary materials in format of tables include the enrollment and exclusion criteria for clinical studies, basic parameters of T2DM patients who took exenatide after 3 months and 6 months, and comparisons between healthy subjects and T2DM patients with different genotypes.Supplementary materials in the form of images include the clinical recruitment process, basic parameters of mice, validation of interference efficiency, and expression of target proteins in animal tissues.